Crystal structure of the single-stranded DNA-binding protein SsbB in complex with the anticancer drug 5-fluorouracil: Extension of the 5-fluorouracil interactome to include the oligonucleotide/oligosaccharide-binding fold protein

doi:10.1016/j.bbrc.2020.11.125

CSMUIR > researcher portal > Artical > Item 310902500/23943

Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/23943

Title:	Crystal structure of the single-stranded DNA-binding protein SsbB in complex with the anticancer drug 5-fluorouracil: Extension of the 5-fluorouracil interactome to include the oligonucleotide/oligosaccharide-binding fold protein
Authors:	Lin, ES;Huang, CY
Keywords:	5-Fluorouracil;SsbB;Interactome;SSB;SsbA;Anticancer
Date:	2021
Issue Date:	2022-08-05T09:45:20Z (UTC)
Publisher:	ACADEMIC PRESS INC ELSEVIER SCIENCE
ISSN:	0006-291X
Abstract:	Single-stranded DNA-binding proteins (SSBs) are essential to cells because they participate in DNA metabolic processes, such as DNA replication, repair, and recombination. Some bacteria possess more than one paralogous SSB. Three similar SSBs, namely, SsbA, SsbB, and SsbC, are found in Staphylococcus aureus. Whether the FDA-approved clinical drug 5-fluorouracil (5-FU) that is used to target the enzyme thymidylate synthase for anticancer therapy can also bind to SSBs remains unknown. In this study, we found that 5-FU could form a stable complex with S. aureus SsbB (SaSsbB). We cocrystallized 5-FU with SaSsbB and solved complex structures to assess binding modes. Two complex forms of the structures were determined, namely, the individual asymmetric unit (two SaSsbB monomers) containing one (PDB entry 7D8J) or two 5-FU molecules (PDB entry 7DEP). The locations of 5-FU in these two SaSsbB complexes were similar regardless of the binding ratio. The structures revealed that residues T12, K13, T30, F48, and N50 of SaSsbB were involved in 5-FU binding. The mutations of T12, K13, and F48 caused the low 5-FU binding activity of SaSsbB, a result consistent with the structural analysis results. Taken together, the complexed structure and the binding mode analysis of SaSsbB extended the anticancer drug 5-FU interactome to include the oligonucleotide/oligosaccharide-binding fold protein. (C) 2020 Elsevier Inc. All rights reserved.
URI:	http://dx.doi.org/10.1016/j.bbrc.2020.11.125 https://www.webofscience.com/wos/woscc/full-record/WOS:000607297600007 https://ir.csmu.edu.tw:8080/handle/310902500/23943
Relation:	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS ,2021,v534 , P41-46
Appears in Collections:	[researcher portal] Artical

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	228	View/Open

Loading...